Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
Lachelle D. Weeks(Harvard University), Benjamin L. Ebert(Dana-Farber Cancer Institute), Alexander G. Bick(Vanderbilt University Medical Center), Caitlyn Vlasschaert(Queen's University), Waihay J. Wong(Brigham and Women's Hospital), Marlise R. Luskin(Dana-Farber Cancer Institute), Abhishek Niroula(Broad Institute), Pradeep Natarajan(Unknown), Christopher J. Gibson(Otsuka (Japan)), Nancy Berliner(Brigham and Women's Hospital), Robert J. Soiffer(Dana-Farber Cancer Institute), Richard M. Stone(Dana-Farber Cancer Institute), Luca Malcovati(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Siddhartha Jaiswal(Stanford University), R. Coleman Lindsley(Harvard University), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Donna Neuberg(Otsuka (Japan)), Gabriel K. Griffin(Brigham and Women's Hospital), Md Mesbah Uddin(Broad Institute)
Cited by 294
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Analysis of protein-coding genetic variation in 60,706 humans
|Nature|2016|10.3k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k